drugset / Trial / NCT03108690

Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia

NCT03108690

Phase 4 Withdrawn Sara Thønnings
RandomizedFactorialSingle-blindTreatment

Summary

The study investigates whether Therapeutic Drug Monitoring (TDM) and continuous infusion (CI) of beta-lactam antibiotics optimises target concentrations in patients with bacteraemia.

Timeline

Start
2017-10-01
Primary completion
2023-03-09
Completion
2023-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ampicillin Unknown
Subject Benzylpenicillin Unknown
Subject Cefuroxime Small molecule
Subject Dicloxacillin Small molecule
Subject Meropenem Small molecule
Subject Piperacillin/tazobactam Unknown